Novel Splice Site Mutation in MAMLD1 in a Patient with Hypospadias

Area of Science:

• Genetics
• Molecular Biology
• Developmental Biology

Background:

• Mutations in the MAMLD1 gene are known causes of disorders of sex development (DSD).
• Previously identified MAMLD1 mutations lead to hypospadias through dysfunctional proteins or unstable mRNA.
• Understanding the precise molecular mechanisms of MAMLD1 mutations is crucial for diagnosing and treating DSD.

Purpose of the Study:

• To investigate the molecular consequences of a newly identified intronic MAMLD1 mutation (g.IVS4-2A>G) in a patient with hypospadias.
• To explore the impact of this mutation on MAMLD1 mRNA splicing and protein expression.
• To assess the functional activity of the mutant MAMLD1 protein.

Main Methods:

• Genetic analysis of a hypospadias patient to identify MAMLD1 mutations.
• RT-PCR to analyze MAMLD1 mRNA expression patterns, including full-length and splice variants.
• In vitro cell-based assays to evaluate mutant protein expression, stability, and transactivation activity.
• Treatment with proteasome and translation inhibitors to study protein regulation.

Main Results:

• An intronic MAMLD1 mutation (g.IVS4-2A>G) was found in one hypospadias patient.
• The mutation led to abnormal splicing, including a novel variant lacking exon 5 and a frameshift mutation in the full-length transcript.
• Mutant MAMLD1 protein showed reduced expression and significantly lower transactivation activity on the Hes3 promoter.
• Mutant protein expression levels were affected by proteasome and translation inhibitors, suggesting post-transcriptional regulation.

Conclusions:

• MAMLD1 mutations can cause hypospadias through splice errors, leading to truncated or unstable transcripts.
• The identified mutation results in a mutant protein with impaired function.
• Translation failure is a potential pathogenic mechanism for MAMLD1 mutants that warrants further investigation.